Acta Pharmaceutica Sinica B
|
2026, 16(2): 746-769
• Reviews •
Activating protein kinases to treat diseases: Current understanding and future challenges
Full
Peng Jin1, Minru Liao2, Huidi Liu3, Kun Huang4, Leilei Fu2, Xin Jin4
Affiliations
1 Department of Urology, Shengjing Hospital of China Medical University, China Medical University, Shenyang 110004, China;
2 Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China;
3 Department of Anus and Intestine Surgery, The First Hospital of China Medical University, China Medical University, Shenyang 110001, China;
4 Department of Ultrasound, The First Hospital of China Medical University, China Medical University, Shenyang 110001, China
doi: 10.1016/j.apsb.2025.12.004
Outline
Protein kinases, as one of the most important human enzymes, are signaling molecules that regulate almost all cell activities, including growth, cell division and metabolism. Dysfunction of these cellular pathways can lead to a variety of human diseases. Accumulating evidence on the down-regulation of key protein kinases in diseases has made a big progress. The down-regulation is related to cancer, heart disease, neurodegenerative diseases and other diseases. Thus, in this review, we defined the classifications of protein kinases and demonstrated the mechanisms of protein kinase activators in the treatment of human diseases, summarized the research progress of protein kinase activators, and further discussed the development progress of protein kinase activators in clinical stage. Accordingly, activation of protein kinases has become a crucial target for drug development. With the in-depth understanding of protein kinase functions and regulation mechanisms, the development of new protein kinase activators may continue to be a rapidly growing field, which will help to develop more accurate and effective targeted therapeutic strategies in the near future.
Protein kinase
/
Activator
/
Human disease
/
Serine/threonine specific protein kinase
/
Tyrosine protein kinase
/
Small-molecule pharmacological agent
/
Clinical trial
/
Therapeutic strategy
Peng Jin, Minru Liao, Huidi Liu, Kun Huang, Leilei Fu, Xin Jin.
Activating protein kinases to treat diseases: Current understanding and future challenges[J].
Acta Pharmaceutica Sinica B,
2026
, 16
(2)
: 746
-769
.
DOI: 10.1016/j.apsb.2025.12.004
Year 2026 volume 16 Issue 2
PDF
7
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.12.004
- Receive Date:2025-07-10
- Online Date:2026-09-17